Literature DB >> 21798958

Negative illness perceptions are associated with impaired quality of life in patients after long-term remission of Cushing's syndrome.

Jitske Tiemensma1, Adrian A Kaptein, Alberto M Pereira, Johannes W A Smit, Johannes A Romijn, Nienke R Biermasz.   

Abstract

OBJECTIVE: Illness perceptions pertain to the pattern of beliefs patients develop about their illness. Illness perceptions are determinants of quality of life (QoL). Factors contributing to persisting impaired QoL after Cushing's syndrome (CS) remain largely unknown. Therefore, the objective of this study was to explore illness perceptions, as potentially modifiable psychological factors, in relation to QoL in patients with long-term remission of CS.
DESIGN: Cross-sectional study.
METHODS: We included patients with long-term remission of CS (n=52). Illness perceptions were evaluated using the Illness Perception Questionnaire (IPQ)-Revised, and QoL was measured using the physical symptom checklist, EuroQoL-5D (EQ-5D), and the CushingQoL. Reference data were derived from recent studies and included patients with vestibular schwannoma (n=80), acute (n=35) or chronic (n=63) pain, and chronic obstructive pulmonary disease (COPD; n=171).
RESULTS: Illness perceptions showed a strong correlation with QoL. Patients with CS scored distinctively more negative on the IPQ compared with patients with vestibular schwannoma and patients with acute pain, and also reported more illness-related complaints (all P<0.01). There were also some differences in illness perceptions between patients with CS and patients with chronic pain and patients with COPD, but there was no distinct pattern.
CONCLUSIONS: Patients after long-term remission of CS report more negative illness perceptions compared with patients with other acute or chronic conditions. Further research is needed to assess whether QoL in CS can be improved by addressing these illness perceptions, for example, by a self-management intervention program.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21798958     DOI: 10.1530/EJE-11-0307

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  27 in total

1.  Towards a better quality of life (QoL) for patients with pituitary diseases: results from a focus group study exploring QoL.

Authors:  Cornelie D Andela; Nicolasine D Niemeijer; Margreet Scharloo; Jitske Tiemensma; Shaaji Kanagasabapathy; Alberto M Pereira; Noëlle G A Kamminga; Ad A Kaptein; Nienke R Biermasz
Journal:  Pituitary       Date:  2015-02       Impact factor: 4.107

2.  Illness perceptions, risk perception and worry in SDH mutation carriers.

Authors:  L T van Hulsteijn; A A Kaptein; A Louisse; N R Biermasz; J W A Smit; E P M Corssmit
Journal:  Fam Cancer       Date:  2014-03       Impact factor: 2.375

3.  Patient and spouse illness beliefs and quality of life in prostate cancer patients.

Authors:  Lisa M Wu; Nihal E Mohamed; Gary Winkel; Michael A Diefenbach
Journal:  Psychol Health       Date:  2012-09-13

4.  Structured nursing educational programs improve quality of life outcomes in patients with Cushing's syndrome.

Authors:  Sofia Llahana; Nicola Thomas
Journal:  Endocrine       Date:  2016-04-05       Impact factor: 3.633

5.  Coping strategies have a strong impact on quality of life, depression, and embitterment in patients with Cushing's disease.

Authors:  Sonja Siegel; Monika Milian; Bernadette Kleist; Tsambika Psaras; Maria Tsiogka; Dagmar Führer; Maria Koltowska-Häggström; Jürgen Honegger; Oliver Müller; Ulrich Sure; Christa Menzel; Michael Buchfelder; Ilonka Kreitschmann-Andermahr
Journal:  Pituitary       Date:  2016-12       Impact factor: 4.107

6.  Resting-State Functional Connectivity in Patients with Long-Term Remission of Cushing's Disease.

Authors:  Steven J A van der Werff; J Nienke Pannekoek; Cornelie D Andela; Onno C Meijer; Mark A van Buchem; Serge A R B Rombouts; Roos C van der Mast; Nienke R Biermasz; Alberto M Pereira; Nic J A van der Wee
Journal:  Neuropsychopharmacology       Date:  2015-02-05       Impact factor: 7.853

7.  Mapping CushingQOL scores to EQ-5D utility values using data from the European Registry on Cushing's syndrome (ERCUSYN).

Authors:  X Badia; M Roset; E Valassi; H Franz; A Forsythe; S M Webb
Journal:  Qual Life Res       Date:  2013-03-29       Impact factor: 4.147

8.  Treatment of Cushing's Syndrome: An Endocrine Society Clinical Practice Guideline.

Authors:  Lynnette K Nieman; Beverly M K Biller; James W Findling; M Hassan Murad; John Newell-Price; Martin O Savage; Antoine Tabarin
Journal:  J Clin Endocrinol Metab       Date:  2015-07-29       Impact factor: 5.958

9.  Lack of functional remission in Cushing's syndrome.

Authors:  M Vermalle; M Alessandrini; T Graillon; N C Paladino; K Baumstarck; F Sebag; H Dufour; T Brue; F Castinetti
Journal:  Endocrine       Date:  2018-07-17       Impact factor: 3.633

Review 10.  Cushing's Disease - Quality of Life, Recurrence and Long-term Morbidity.

Authors:  Isabel Huguet; Georgia Ntali; Ashley Grossman; Niki Karavitaki
Journal:  Eur Endocrinol       Date:  2015-04-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.